334 related articles for article (PubMed ID: 18414086)
1. Measuring cognitive function with age: the influence of selection by health and survival.
Euser SM; Schram MT; Hofman A; Westendorp RG; Breteler MM
Epidemiology; 2008 May; 19(3):440-7. PubMed ID: 18414086
[TBL] [Abstract][Full Text] [Related]
2. Serum calcium and cognitive function in old age.
Schram MT; Trompet S; Kamper AM; de Craen AJ; Hofman A; Euser SM; Breteler MM; Westendorp RG
J Am Geriatr Soc; 2007 Nov; 55(11):1786-92. PubMed ID: 17979900
[TBL] [Abstract][Full Text] [Related]
3. The effect of age on the association between blood pressure and cognitive function later in life.
Euser SM; van Bemmel T; Schram MT; Gussekloo J; Hofman A; Westendorp RG; Breteler MM
J Am Geriatr Soc; 2009 Jul; 57(7):1232-7. PubMed ID: 19453303
[TBL] [Abstract][Full Text] [Related]
4. Systemic markers of inflammation and cognitive decline in old age.
Schram MT; Euser SM; de Craen AJ; Witteman JC; Frölich M; Hofman A; Jolles J; Breteler MM; Westendorp RG
J Am Geriatr Soc; 2007 May; 55(5):708-16. PubMed ID: 17493190
[TBL] [Abstract][Full Text] [Related]
5. Generalized atherosclerosis, cognitive decline, and depressive symptoms in old age.
Vinkers DJ; Stek ML; van der Mast RC; de Craen AJ; Le Cessie S; Jolles J; Westendorp RG; Gussekloo J
Neurology; 2005 Jul; 65(1):107-12. PubMed ID: 16009894
[TBL] [Abstract][Full Text] [Related]
6. Selective non-response to clinical assessment in the longitudinal study of aging: implications for estimating population levels of cognitive function and dementia.
Anstey KJ; Luszcz MA
Int J Geriatr Psychiatry; 2002 Aug; 17(8):704-9. PubMed ID: 12211118
[TBL] [Abstract][Full Text] [Related]
7. The metabolic syndrome is associated with decelerated cognitive decline in the oldest old.
van den Berg E; Biessels GJ; de Craen AJ; Gussekloo J; Westendorp RG
Neurology; 2007 Sep; 69(10):979-85. PubMed ID: 17785666
[TBL] [Abstract][Full Text] [Related]
8. Influence of cognitive functioning on functional status in an older population: 3- and 6-year follow-up of the Maastricht Aging Study.
van Hooren SA; van Boxtel MP; Valentijn SA; Bosma H; Ponds RW; Jolles J
Int J Geriatr Psychiatry; 2005 Sep; 20(9):883-8. PubMed ID: 16116574
[TBL] [Abstract][Full Text] [Related]
9. Terminal cognitive decline: accelerated loss of cognition in the last years of life.
Wilson RS; Beck TL; Bienias JL; Bennett DA
Psychosom Med; 2007; 69(2):131-7. PubMed ID: 17327212
[TBL] [Abstract][Full Text] [Related]
10. Hyperinsulinemia and cognitive decline in a middle-aged cohort.
Young SE; Mainous AG; Carnemolla M
Diabetes Care; 2006 Dec; 29(12):2688-93. PubMed ID: 17130206
[TBL] [Abstract][Full Text] [Related]
11. No protective effects of education during normal cognitive aging: results from the 6-year follow-up of the Maastricht Aging Study.
Van Dijk KR; Van Gerven PW; Van Boxtel MP; Van der Elst W; Jolles J
Psychol Aging; 2008 Mar; 23(1):119-30. PubMed ID: 18361661
[TBL] [Abstract][Full Text] [Related]
12. 12-month cognitive outcomes of major and minor depression in older medical patients.
Han L; McCusker J; Cole M; Abrahamowicz M; Capek R
Am J Geriatr Psychiatry; 2008 Sep; 16(9):742-51. PubMed ID: 18757768
[TBL] [Abstract][Full Text] [Related]
13. Asymptomatic spontaneous cerebral emboli and cognitive decline in a cohort of older people: a prospective study.
Voshaar RC; Purandare N; Hardicre J; McCollum C; Burns A
Int J Geriatr Psychiatry; 2007 Aug; 22(8):794-800. PubMed ID: 17192026
[TBL] [Abstract][Full Text] [Related]
14. Type 2 diabetes mellitus contributes to cognitive decline in old age: a longitudinal population-based study.
Hassing LB; Grant MD; Hofer SM; Pedersen NL; Nilsson SE; Berg S; McClearn G; Johansson B
J Int Neuropsychol Soc; 2004 Jul; 10(4):599-607. PubMed ID: 15327738
[TBL] [Abstract][Full Text] [Related]
15. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study.
Knopman DS; Mosley TH; Catellier DJ; Coker LH;
Alzheimers Dement; 2009 May; 5(3):207-14. PubMed ID: 19362884
[TBL] [Abstract][Full Text] [Related]
16. A cross-sectional and longitudinal study of the relationship between walking speed and cognitive function in community-dwelling elderly people.
Soumaré A; Tavernier B; Alpérovitch A; Tzourio C; Elbaz A
J Gerontol A Biol Sci Med Sci; 2009 Oct; 64(10):1058-65. PubMed ID: 19561146
[TBL] [Abstract][Full Text] [Related]
17. Plasma selenium over time and cognitive decline in the elderly.
Akbaraly TN; Hininger-Favier I; Carrière I; Arnaud J; Gourlet V; Roussel AM; Berr C
Epidemiology; 2007 Jan; 18(1):52-8. PubMed ID: 17130689
[TBL] [Abstract][Full Text] [Related]
18. Physical activity and 5-year cognitive decline in the Doetinchem cohort study.
Angevaren M; Vanhees L; Nooyens AC; Wendel-Vos CG; Verschuren WM
Ann Epidemiol; 2010 Jun; 20(6):473-9. PubMed ID: 20470975
[TBL] [Abstract][Full Text] [Related]
19. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
20. Education, atrophy, and cognitive change in an epidemiological sample in early old age.
Christensen H; Batterham PJ; Mackinnon AJ; Anstey KJ; Wen W; Sachdev PS
Am J Geriatr Psychiatry; 2009 Mar; 17(3):218-26. PubMed ID: 19454848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
